Читать «Антираковая диета. Продукты, которые мы должны есть, чтобы защититься от опасного недуга» онлайн - страница 118

{28} Athar M., Back J. H., Kopelovich L., Bickers D. R., Kim A. L., «Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms», Arch. Biochem. Biophys., 2009, 486 (2), p. 95—102.

{29} Yusuf N., Nasti T. H., Meleth S., «Elmets CA. Resveratrol enhances cellmediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis», Mol. Carcinog., 2009, 48 (8), p. 713–723.

{30} Seeni A., Takahashi S., Takeshita K., Tang M., Sugiura S., Sato S. Y., Shirai T., «Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model», Asian Pac. J. Cancer Prev., 2008, 9 (1), p. 7—14.

{31} Sengottuvelan M., Deeptha K., Nalini N., «Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazineinduced colon carcinogenesis», Nutrition, 2009, 25 (11–12), p. 1169–1176.

{32} Ding X. Z., Adrian T. E., «Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells», Pancreas, 2002, 25 (4), p. 71–76.

{33} Woodall C. E., Li Y., Liu Q. H., Wo J., Martin R. C., «Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation», Anticancer Drugs, 2009, 20 (6), p. 437–443.

{34} AFSSA, «Table CIQUAL 2008», op. cit.

{35} Direction générale de la Santé, Cancer de la peau. Mélanome, 2003. Disponible sur: http://www.sante.gouv.fr/htm/dossiers/losp/34cancer_ peau.pdf (consulté le 18 mars 2010).

{36} AFSSET, FAQ Rayonnement ultraviolet. Disponible sur: http:// www.afsset.fr/index.php?pageid=634 & parentid=265&ongletlstid=427 (consulté le 17 mars 2010).

{37} Sayre R. M., Dowdy J. C., «The increase in melanoma: are dietary furocoumarins responsable?», Med Hypotheses, 2008, 70 (4), p. 855–859.

{38} Feskanich D., Willett W. C., Hunter D. J., Colditz G. A., «Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women», Br. J. Cancer, 2003, 88 (9), p. 1381–1387.

{39} Malik A., Afaq F., Sarfaraz S., Adhami V. M., Syed D. N., Mukhtar H., «Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer», Proc. Natl. Acad. Sci., 2005, 102 (41), p. 14813—14818.

{40} Pantuck A. J., Leppert J. T., Zomorodian N., Aronson W., Hong J., Barnard R. J., Seeram N., Liker H., Wang H., Elashoff R., Heber D., Aviram M., Ignarro L., Belldegrun A., «Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer», Clin. Cancer Res., 2006, 12 (13), p. 4018–4026.

{41} Zhang Y., Seeram N. P., Heber D., Chen S., Adams L. S., «Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro», Cancer Prev. Res. (Phila Pa), 2010, 3 (1), p. 108–113.

{42} Khan G. N., Gorin M. A., Rosenthal D., Pan Q., Bao L. W., Wu Z. F., Newman R. A., Pawlus A. D., Yang P., Lansky E. P., Merajver S. D., «Pomegranate fruit extract impairs invasion and motility in human breast cancer», Integr. Cancer Ther., 2009, 8 (3), p. 242–253.